Results suggest that SHP1 may be a potential target for muscle insulin resistance and insulin signaling during obesity, as well as the fact that it may be involved in the development of non-alcoholic fatty liver disease caused by diet-induced obesity [64,65,66]. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.